Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: Case report and literature review

Endocrine Practice

Volumn 14, Issue 4, 2008, Pages 479-483

  Watkins, Mark G ^a   Dejkhamron, Prapai ^a   Huo, Jeffrey ^a   Vazquez, Delia M ^a   Menon, Ram K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DNA; GAMMA GLUTAMYLTRANSFERASE; LUGOL; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DNA DETERMINATION; FAILURE TO THRIVE; GENE ACTIVATION; GENE MUTATION; HEPATOMEGALY; HUMAN; HYPERTHYROIDISM; MALE; MECONIUM ASPIRATION; NEWBORN; NEWBORN DISEASE; PNEUMOTHORAX; THYROID FUNCTION; THYROTOXICOSIS; GENETICS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVIEW;

DNA MUTATIONAL ANALYSIS; HUMANS; INFANT, NEWBORN; MALE; MUTATION, MISSENSE; RECEPTORS, THYROTROPIN; THYROTOXICOSIS;

EID: 58149375164     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.4.479     Document Type: Article

References (17)

1. Polak M. Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid. 1998;8:1171-1177.
2. Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol. 1994;130:565-568.
3. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol. 1995;9:725-733.
4. Tonacchera M, Agretti P, Rosellini V, et al. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid. 2000;10:859-863.
5. Börgel K, Pohlenz J, Koch HG, Bramswig JH. Long-term carbimazole treatment of neonatal nonautoimmune hyperthyroidism due to a new activating TSH receptor gene mutation (Ala428Val). Horm Res. 2005;64:203-208.
6. Karges B, Krause G, Homoki J, Debatin K, de Roux N, Karges W. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol. 2005;186:377-385.
7. Duprez L, Parma J, Van Sande J, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet. 1994;7:396-401.
8. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Führer D. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid. 2005;15:1089-1094.
9. Elgadi A, Arvidsson C, Janson A, Marcus C, Costagliola S, Norgren, S. Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms. Acta Paediatr. 2005;94:1145-1148.
10. Biebermann H, Schöneberg T, Hess C, Germak J, Gudermann T, Grüters A. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab. 2001;86:4429-4433.
11. Ringkananont U, Van Durme J, Montanelli L, et al. Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I). Mol Endocrinol. 2006;20:893-903.
12. Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid. 2006;16:505-512.
13. Pohlenz J, Pfarr N, Krüger S, Hesse V. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatr. 2006;95:1685-1687.
14. Tonacchera M, Van Sande J, Cetani F, et al. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 1996;81:547-554.
15. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D. Congenital hyperthyroidism: the fetus as a patient. Horm Res. 2006;65:235-242.
16. McCarthy M, McNair ANB, Pinto T. Cholestatic jaundice associated with hyperthyroidism in the absence of heart failure. CME Gastroenterology. 2001;4:69-71.
17. Sola J, Pardo-Mindán FJ, Zozaya J, Quiroga J, Sangro B, Prieto J. Liver changes in patients with hyperthyroidism. Liver. 1991;11:193-197.